KRSNAA563.45

Krsnaa Diagnostics Limited

· Pharma & Health
₹ CrorePeersSURAKSHAHEALTHXNEPHROPLUS3BBLACKBIOMcap ₹1,828 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)92.6763.5654.3454.34
Receivable Days (DSO)103.85141.36139.57139.57
Payable Days (DPO)213.03209.45128.84126.89
Cash Conversion Cycle (days)-16.51-4.5365.0767.02
Working Capital Turnover4.436.571.671.76
Asset Turnover0.530.560.420.42
Cash Conversion (CFO/Net Income)0.431.131.411.41
CFO/EBITDA0.170.460.680.68
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.